LoginRegister

    Dr Reddys gets EIR from USFDA for manufacturing plants at Duvvada

    Medical Dialogues BureauWritten by Medical Dialogues Bureau   |  

    The company has received EIR from the United States Food and Drug Administration (USFDA) for the inspection conducted at the formulations manufacturing plants at Duvvada Visakhapatnam, Dr Reddy's Laboratories said in a regulatory filing.


    New Delhi: Dr Reddy's Laboratories on Thursday said it has received establishment inspection report (EIR) from the US health regulator for its Visakhapatnam facility in Andhra Pradesh.


    The company has received EIR from the United States Food and Drug Administration (USFDA) for the inspection conducted at the formulations manufacturing plants at Duvvada Visakhapatnam, Dr Reddy's Laboratories said in a regulatory filing.


    Read Also: Dr Reddys unveils a generic version of Zyban ER tablets in the US


    The inspection of the two facilities were completed by the USFDA on June 21 this year, it added.


    "We have now received an EIR from the USFDA, indicating closure of this audit," the company said.


    The USFDA gives EIR on closure of inspection of an establishment that is the subject of USFDA or USFDA-contracted inspection.


    Read Also: Dr Reddys gets 8 USFDA observations for Duvvada facility in Andhra Pradesh

    BSEDr Reddy'sDr Reddy's LaboratoriesDr Reddy's Labsdr reddys vizagDuvvadaEIREstablishment Inspection Reportpharmapharma companypharma newspharma news indiaUnited States Food and Drug AdministrationUSFDAUSFDA inspectionUSFDA observationsVisakhapatnamVizag units
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X